Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

1(25.0%)

Phase 1

1(25.0%)

Phase 3

1(25.0%)

N/A

1(25.0%)

4Total

Phase 2(1)

Phase 1(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT02378584Not ApplicableCompleted

Natural Cycle Versus Endometrial Preparation for Healthy Blastocyst Transfer

Role: lead

NCT02575924Phase 1Unknown

Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility

Role: lead

NCT00818792Phase 2Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease

Role: lead

NCT01636505Phase 3Unknown

The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

Role: lead

All 4 trials loaded